Total Payments
$5,872
2024 Payments
$391.54
Companies
23
Transactions
96
Medicare Patients
3,412
Medicare Billing
$458,839
Payment Breakdown by Category
Food & Beverage$3,962 (67.5%)
Travel$1,098 (18.7%)
Consulting$500.00 (8.5%)
Gifts$311.37 (5.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,962 | 86 | 67.5% |
| Travel and Lodging | $1,098 | 3 | 18.7% |
| Consulting Fee | $500.00 | 1 | 8.5% |
| Gift | $311.37 | 6 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,320 | 27 | $0 (2023) |
| PENTAX of America, Inc. | $556.70 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $476.86 | 4 | $0 (2023) |
| Braintree Laboratories, Inc. | $311.37 | 6 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $300.15 | 5 | $0 (2017) |
| Ardelyx, Inc. | $270.41 | 3 | $0 (2024) |
| Gilead Sciences Inc | $249.92 | 2 | $0 (2017) |
| Allergan Inc. | $226.31 | 2 | $0 (2019) |
| Apollo Endosurgery US Inc | $212.92 | 5 | $0 (2019) |
| Celgene Corporation | $211.14 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $391.54 | 18 | Janssen Biotech, Inc. ($63.94) |
| 2023 | $1,212 | 23 | PENTAX of America, Inc. ($556.70) |
| 2022 | $808.02 | 8 | Boston Scientific Corporation ($245.57) |
| 2021 | $353.81 | 4 | E.R. Squibb & Sons, L.L.C. ($227.09) |
| 2020 | $53.32 | 1 | Braintree Laboratories, Inc. ($53.32) |
| 2019 | $1,007 | 19 | Boston Scientific Corporation ($497.68) |
| 2018 | $1,363 | 13 | BOSTON SCIENTIFIC CORPORATION ($1,363) |
| 2017 | $682.65 | 10 | Merck Sharp & Dohme Corporation ($300.15) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: LIVER DISEASE | ||||||
| 11/12/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: LIVER DISEASE | ||||||
| 10/25/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Genetic Disease | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: Immunology | ||||||
| 08/22/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $29.28 | General |
| Category: THERAPY FOR CSID | ||||||
| 02/27/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.44 | General |
| Category: Neuroscience | ||||||
| 01/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.43 | General |
| Category: Neuroscience | ||||||
| 01/25/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/20/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| Category: Neuroscience | ||||||
| 11/06/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.08 | General |
| Category: Neuroscience | ||||||
| 11/02/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $133.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.34 | General |
| Category: Neuroscience | ||||||
| 10/13/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/12/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $8.00 | General |
| Category: Neuroscience | ||||||
| 09/18/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $1.61 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 853 | 958 | $453,285 | $107,553 |
| 2022 | 15 | 925 | 1,085 | $465,480 | $127,423 |
| 2021 | 16 | 810 | 991 | $475,600 | $122,746 |
| 2020 | 17 | 824 | 996 | $465,780 | $101,116 |
Total Patients
3,412
Total Services
4,030
Medicare Billing
$458,839
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 209 | $48,690 | $21,069 | 43.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 65 | 65 | $78,650 | $14,123 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 147 | 184 | $29,810 | $12,365 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $26,785 | $10,369 | 38.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 117 | 117 | $26,745 | $9,421 | 35.2% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 49 | 51 | $47,430 | $8,953 | 18.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 35 | 35 | $28,350 | $6,805 | 24.0% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 26 | 28 | $25,200 | $6,299 | 25.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 79 | 79 | $61,020 | $6,128 | 10.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 58 | 58 | $51,370 | $5,814 | 11.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $13,770 | $2,422 | 17.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $5,565 | $2,277 | 40.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $9,900 | $1,508 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 282 | $57,810 | $29,563 | 51.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 193 | $27,020 | $14,421 | 53.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 60 | 62 | $75,020 | $13,922 | 18.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 93 | 93 | $29,295 | $12,126 | 41.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 123 | 123 | $25,830 | $11,411 | 44.2% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 51 | 52 | $48,360 | $10,063 | 20.8% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 34 | 34 | $30,600 | $7,100 | 23.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 75 | 78 | $56,160 | $6,333 | 11.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 52 | 52 | $45,240 | $5,733 | 12.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 24 | 24 | $19,440 | $4,526 | 23.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 19 | 19 | $15,390 | $3,934 | 25.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $6,890 | $3,100 | 45.0% |
About Dr. Kasra Adham, MD
Dr. Kasra Adham, MD is a Gastroenterology healthcare provider based in Oxon Hill, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2010. The National Provider Identifier (NPI) number assigned to this provider is 1053630285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kasra Adham, MD has received a total of $5,872 in payments from pharmaceutical and medical device companies, with $391.54 received in 2024. These payments were reported across 96 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,962).
As a Medicare-enrolled provider, Adham has provided services to 3,412 Medicare beneficiaries, totaling 4,030 services with total Medicare billing of $458,839. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Oxon Hill, MD
- Active Since 05/27/2010
- Last Updated 02/06/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053630285
Products in Payments
- AXIOS (Device) $893.23
- ZEPOSIA (Drug) $660.77
- GENERAL THERAPIES (Device) $402.18
- SPYGLASS (Device) $330.75
- ZEPATIER (Drug) $300.15
- IBSRELA (Drug) $270.41
- SUTAB (Drug) $204.73
- Overstitch (Device) $200.00
- FUJIFILM (Device) $195.67
- EXALT Model D (Device) $160.68
- SPYSCOPE (Device) $138.93
- Acquire (Device) $130.13
- Vemlidy (Drug) $124.98
- Epclusa (Drug) $124.94
- VIBERZI (Drug) $120.34
- ACQUIRE (Device) $118.41
- General - Biopsy (Device) $115.44
- SUPREP BOWEL PREP (Drug) $106.64
- LINZESS (Drug) $105.97
- SHINGRIX (Drug) $105.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oxon Hill
Karen Chachu, Md, MD
Gastroenterology — Payments: $18,849
Gastroenterology $18,849
Dr. Jonathan Mccone, M.d, M.D
Gastroenterology — Payments: $4,951
Gastroenterology $4,951
Dr. Eric Lavery, M.d, M.D
Gastroenterology — Payments: $3,742
Gastroenterology $3,742
Dr. Abdulhosein Adham, M.d, M.D
Gastroenterology — Payments: $2,002
Gastroenterology $2,002
Sachin Mohan
Gastroenterology — Payments: $1,004
Gastroenterology $1,004